LISATA THERAPEUTICS, INC.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 4, 2026 (9 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| May 15, 2026 | HC Wainwright & Co. | downgrade | Buy → Neutral | — | 44% |
| Jan 21, 2026 | Brookline Capital | downgrade | Buy → Hold | $0 | 38% |
| Aug 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jul 15, 2025 | Brookline Capital | maintain | Buy → Buy | $32 | 38% |
| Dec 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Nov 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Sep 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Aug 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jul 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jul 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jun 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| May 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Apr 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Apr 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Mar 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Jan 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Aug 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| May 25, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Mar 31, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $15 | 44% |
| Oct 19, 2022 | HC Wainwright & Co. | maintain | — → Buy | $15 | 44% |
No cross-platform signals in the last 90 days